- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期行情可能回暖，可适量买进股票，作短线反弹行情。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有257家主力机构披露2025-06-30报告期持股数据，持仓量总计9.74亿股，占流通A股49.71%
- 波段诊断：
-
技术面诊股
诊断结果：5.0技术面打败了21%的股票
技术面评分前10的股票
近期的平均成本为8.26元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为8.26元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.26","date":1758098077,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2025.09.18","stock":"0.00","trade":"-0.43","ind":"-1.15"},{"date":"2025.09.17","stock":"-0.96","trade":"-0.76","ind":"0.37"},{"date":"2025.09.16","stock":"-0.84","trade":"-0.13","ind":"0.04"},{"date":"2025.09.15","stock":"0.12","trade":"-0.30","ind":"-0.26"},{"date":"2025.09.12","stock":"-0.83","trade":"0.40","ind":"-0.12"},{"date":"2025.09.11","stock":"0.12","trade":"0.93","ind":"1.65"},{"date":"2025.09.10","stock":"-1.29","trade":"-0.72","ind":"0.13"},{"date":"2025.09.09","stock":"-1.95","trade":"-1.80","ind":"-0.51"},{"date":"2025.09.08","stock":"1.75","trade":"0.58","ind":"0.38"},{"date":"2025.09.05","stock":"0.94","trade":"2.42","ind":"1.24"},{"date":"2025.09.04","stock":"-1.17","trade":"-2.38","ind":"-1.25"},{"date":"2025.09.03","stock":"-0.23","trade":"-0.53","ind":"-1.16"},{"date":"2025.09.02","stock":"-0.58","trade":"-1.36","ind":"-0.45"},{"date":"2025.09.01","stock":"2.85","trade":"3.19","ind":"0.46"},{"date":"2025.08.29","stock":"0.84","trade":"1.06","ind":"0.37"},{"date":"2025.08.28","stock":"-1.77","trade":"-0.40","ind":"1.14"},{"date":"2025.08.27","stock":"-2.53","trade":"-2.79","ind":"-1.76"},{"date":"2025.08.26","stock":"1.16","trade":"-0.99","ind":"-0.39"},{"date":"2025.08.25","stock":"1.77","trade":"1.41","ind":"1.51"},{"date":"2025.08.22","stock":"-0.35","trade":"-0.02","ind":"1.45"},{"date":"2025.08.21","stock":"0.12","trade":"0.11","ind":"0.13"}]
通化东宝,上证指数,生物制品指数
压力支撑
该股压力位为8.26元，支撑位为8.16元。
[{"text":"\u538b\u529b\u4f4d","value":"8.26","date":1758124800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.16","date":1758124800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.3资金面打败了11%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：09月18日 20:30
| 机构今日流向(万元) | -2882.76 | 机构5日流向(万元) | -9204.10 |
| 机构10日流向(万元) | -11780.97 | 机构20日流向(万元) | -33015.80 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加1254.19万股，其中基金净减仓67家，主力净增仓62家，请投资者中长期谨慎为宜。
截止2025-06-30，共257家主力机构（基金252家，一般法人4家，QFII1家），持仓量总计97358.09万股，占流通A股49.71%
其中，基金持仓与2024-12-31相比：
增仓：29家 ，增持 458.14万股
减仓：96家 ，减持 2324.48万股
新出现在主力名单中：117家 ，持有2444.28万股
从主力名单中消失：55家 ，原持有915.52万股
其中，基金持仓与2024-12-31相比：
增仓：29家 ，增持 458.14万股
减仓：96家 ，减持 2324.48万股
新出现在主力名单中：117家 ，持有2444.28万股
从主力名单中消失：55家 ，原持有915.52万股
消息面诊股
诊断结果：5.6消息面打败了59%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 研判2025！中国门冬胰岛素市场政策汇总、产业链、
2025-09-18 - 通化东宝：9月17日获融资买入2051.17万元
2025-09-18 - 2024年胰岛素注射液行业发展现状、竞争格局及未来
2025-09-17 - 2025年中国甘精胰岛素市场政策、产业链图谱、市场
2025-09-17 - 通化东宝：9月16日获融资买入1345.07万元
2025-09-17 - 创新药板块四大主线，2025最全高景气公司梳理（附
2025-09-16 - 通化东宝：9月15日获融资买入898.43万元，占
2025-09-16 - 创新药+医药设备+国产替代，最全业绩弹性公司名单
2025-09-15 - 通化东宝：9月12日获融资买入1414.68万元
2025-09-13 - 通化东宝：9月11日获融资买入1590.68万元，
2025-09-12
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-09-03 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 高管变动 | 调整第十一届董事会审计委员会人员构... | 2025-08-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-26 |
| 利好 | 业绩预告 | 预计扭亏 | 2025-07-15 |
| 一般消息 | 高管变动 | 个人原因 | 2025-07-04 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-07-04 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-09 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2025-04-30 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-04-28 |
| 一般消息 | 高管变动 | 因公司组织架构及管理分工安排调整原... | 2025-03-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-11 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-02-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-20 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-11 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-08 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-04 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-09 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-09-21 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 3条 | 2条 | 1条 |
行业面诊股
诊断结果：6.2行业面打败了77%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.09.18","price":"-1.15","value":"-0.43"},{"date":"2025.09.17","price":"0.37","value":"-0.76"},{"date":"2025.09.16","price":"0.04","value":"-0.13"},{"date":"2025.09.15","price":"-0.26","value":"-0.30"},{"date":"2025.09.12","price":"-0.12","value":"0.40"},{"date":"2025.09.11","price":"1.65","value":"0.93"},{"date":"2025.09.10","price":"0.13","value":"-0.72"},{"date":"2025.09.09","price":"-0.51","value":"-1.80"},{"date":"2025.09.08","price":"0.38","value":"0.58"},{"date":"2025.09.05","price":"1.24","value":"2.42"},{"date":"2025.09.04","price":"-1.25","value":"-2.38"},{"date":"2025.09.03","price":"-1.16","value":"-0.53"},{"date":"2025.09.02","price":"-0.45","value":"-1.36"},{"date":"2025.09.01","price":"0.46","value":"3.19"},{"date":"2025.08.29","price":"0.37","value":"1.06"},{"date":"2025.08.28","price":"1.14","value":"-0.40"},{"date":"2025.08.27","price":"-1.76","value":"-2.79"},{"date":"2025.08.26","price":"-0.39","value":"-0.99"},{"date":"2025.08.25","price":"1.51","value":"1.41"},{"date":"2025.08.22","price":"1.45","value":"-0.02"},{"date":"2025.08.21","price":"0.13","value":"0.11"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 迈威生物 | 49.51% | 8.16% | 5.2分 |
| 2 | 荣昌生物 | 32.88% | -5.06% | 6.0分 |
| 3 | 长春高新 | 25.92% | 4.78% | 6.5分 |
| 4 | ST未名 | 16.54% | 14.88% | 5.3分 |
| 5 | 西藏药业 | 14.09% | -4.31% | 6.3分 |
| 6 | 义翘神州 | 11.27% | 2.68% | 5.6分 |
| 8 | 甘李药业 | 7.80% | -2.31% | 6.1分 |
| 10 | 百普赛斯 | 3.33% | 2.64% | 4.9分 |
| 12 | *ST四环 | 1.75% | -1.28% | 4.6分 |
| 14 | 君实生物 | 0.82% | -4.19% | 5.7分 |
| 16 | 昊帆生物 | -2.19% | 5.04% | 5.9分 |
| 18 | 通化东宝 | -3.06% | -2.49% | 5.2分 |
| 20 | 派林生物 | -4.11% | -3.47% | 5.1分 |
| 22 | 天坛生物 | -4.95% | -1.46% | 5.4分 |
| 24 | 康泰生物 | -5.60% | -7.35% | 4.4分 |
| 26 | 成大生物 | -6.05% | -2.20% | 5.7分 |
| 28 | 东宝生物 | -6.93% | -1.05% | 5.7分 |
| 30 | 万泽股份 | -7.15% | -2.92% | 5.6分 |
| 32 | 金迪克 | -7.54% | -2.50% | 5.5分 |
| 34 | 卫光生物 | -7.71% | -3.27% | 5.0分 |
| 36 | 安科生物 | -7.83% | -0.37% | 4.8分 |
| 38 | 近岸蛋白 | -8.10% | -1.91% | 4.5分 |
| 40 | 艾迪药业 | -8.81% | -0.26% | 5.4分 |
| 42 | 百克生物 | -9.85% | -3.85% | 5.2分 |
| 44 | 博晖创新 | -10.39% | -2.53% | 5.0分 |
| 46 | 康华生物 | -12.01% | -0.94% | 5.5分 |
| 48 | 赛升药业 | -14.24% | -2.48% | 4.4分 |
| 50 | - | -14.94% | -0.12% | 分 |
| 52 | 凯因科技 | -17.72% | -0.07% | 5.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 13/72 ， 29/72。
[{"date":"2025-06-30","value":"3.48","vol":"-0.34"},{"date":"2025-03-31","value":"1.70","vol":"0.63"},{"date":"2024-12-31","value":"-0.63","vol":"-0.24"},{"date":"2024-09-30","value":"-0.97","vol":"1.37"},{"date":"2024-06-30","value":"-3.36","vol":"0.72"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.48 | 1.70 | -0.63 | -0.97 | -3.36 |
| 行业(%) | -0.34 | 0.63 | -0.24 | 1.37 | 0.72 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"71.45","vol":"68.47"},{"date":"2025-03-31","value":"69.32","vol":"69.78"},{"date":"2024-12-31","value":"73.90","vol":"69.97"},{"date":"2024-09-30","value":"74.47","vol":"70.57"},{"date":"2024-06-30","value":"72.95","vol":"69.89"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
71.45 | 69.32 | 73.90 | 74.47 | 72.95 |
| 行业(%) | 68.47 | 69.78 | 69.97 | 70.57 | 69.89 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，两项指标的行业排名分别为 3/72 ， 2/72。
[{"date":"2025-06-30","value":"85.60","vol":"7036.72"},{"date":"2025-03-31","value":"10.17","vol":"6246.12"},{"date":"2024-12-31","value":"-34.66","vol":"48.20"},{"date":"2024-09-30","value":"-30.78","vol":"178.44"},{"date":"2024-06-30","value":"-45.84","vol":"19.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
85.60 | 10.17 | -34.66 | -30.78 | -45.84 |
| 行业(%) | 7036.72 | 6246.12 | 48.20 | 178.44 | 19.75 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"194.48","vol":"5.62"},{"date":"2025-03-31","value":"-49.15","vol":"-7.36"},{"date":"2024-12-31","value":"-103.66","vol":"-10.38"},{"date":"2024-09-30","value":"-108.73","vol":"-53.42"},{"date":"2024-06-30","value":"-147.54","vol":"-9.25"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
194.48 | -49.15 | -103.66 | -108.73 | -147.54 |
| 行业(%) | 5.62 | -7.36 | -10.38 | -53.42 | -9.25 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 15/72 ， 17/72。
[{"date":"2025-06-30","value":"0.18","vol":"0.14"},{"date":"2025-03-31","value":"0.09","vol":"0.06"},{"date":"2024-12-31","value":"0.27","vol":"0.29"},{"date":"2024-09-30","value":"0.19","vol":"0.22"},{"date":"2024-06-30","value":"0.10","vol":"0.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.18 | 0.09 | 0.27 | 0.19 | 0.10 |
| 行业(次) | 0.14 | 0.06 | 0.29 | 0.22 | 0.14 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.53","vol":"0.57"},{"date":"2025-03-31","value":"0.27","vol":"0.26"},{"date":"2024-12-31","value":"0.73","vol":"1.19"},{"date":"2024-09-30","value":"0.50","vol":"0.87"},{"date":"2024-06-30","value":"0.27","vol":"0.55"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.53 | 0.27 | 0.73 | 0.50 | 0.27 |
| 行业(次) | 0.57 | 0.26 | 1.19 | 0.87 | 0.55 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，两项指标的行业排名分别为 10/72 ， 21/72。
[{"date":"2025-06-30","value":"30.25","vol":"-1392.00"},{"date":"2025-03-31","value":"15.19","vol":"-47.52"},{"date":"2024-12-31","value":"41.76","vol":"-9.01"},{"date":"2024-09-30","value":"13.70","vol":"-29.47"},{"date":"2024-06-30","value":"-16.86","vol":"-36875.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 30.25 | 15.19 | 41.76 | 13.70 | -16.86 |
| 行业 | -1392.00 | -47.52 | -9.01 | -29.47 | -36875.39 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.97","vol":"1.46"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.77","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"43.98","vol":"2.72"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.97 | - | 2.77 | - | 43.98 |
| 行业 | 1.46 | 0.00 | 2.00 | 0.00 | 2.72 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 1/72 ， 4/72。
[{"date":"2025-06-30","value":"1.76","vol":"6.75"},{"date":"2025-03-31","value":"2.89","vol":"7.90"},{"date":"2024-12-31","value":"3.02","vol":"6.83"},{"date":"2024-09-30","value":"4.30","vol":"7.16"},{"date":"2024-06-30","value":"4.99","vol":"7.04"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.76 | 2.89 | 3.02 | 4.30 | 4.99 |
| 行业 | 6.75 | 7.90 | 6.83 | 7.16 | 7.04 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.17","vol":"5.39"},{"date":"2025-03-31","value":"1.72","vol":"6.47"},{"date":"2024-12-31","value":"1.80","vol":"5.50"},{"date":"2024-09-30","value":"2.32","vol":"5.77"},{"date":"2024-06-30","value":"2.77","vol":"5.91"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.17 | 1.72 | 1.80 | 2.32 | 2.77 |
| 行业 | 5.39 | 6.47 | 5.50 | 5.77 | 5.91 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 25/72 ， 26/72。
[{"date":"2025-06-30","value":"21.80","vol":"26.08"},{"date":"2025-03-31","value":"13.73","vol":"25.48"},{"date":"2024-12-31","value":"13.26","vol":"25.46"},{"date":"2024-09-30","value":"9.74","vol":"24.92"},{"date":"2024-06-30","value":"7.78","vol":"24.62"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
21.80 | 13.73 | 13.26 | 9.74 | 7.78 |
| 行业(%) | 26.08 | 25.48 | 25.46 | 24.92 | 24.62 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.28","vol":"1.11"},{"date":"2025-03-31","value":"0.16","vol":"0.78"},{"date":"2024-12-31","value":"0.15","vol":"0.88"},{"date":"2024-09-30","value":"0.11","vol":"0.41"},{"date":"2024-06-30","value":"0.08","vol":"0.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.28 | 0.16 | 0.15 | 0.11 | 0.08 |
| 行业(%) | 1.11 | 0.78 | 0.88 | 0.41 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华泰金融(HK) | 2025-09-09 | 买入 | |
| 东方证券 | 2025-09-08 | 买入 | |
| 财通证券 | 2025-09-01 | 增持 | 增持 |
| 平安证券 | 2025-08-28 | 增持 | |
| 华泰证券 | 2025-08-25 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"13.08","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"15.82","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.43","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"6.67","blueLineValue":"0.34","type":"YC"}]